Benjamin F. Edwards & Company, Inc. Neogenomics Inc Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 411 shares of NEO stock, worth $5,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares

411

Previous 222 85.14%

Holding current value

$5,803

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.01 - $15.77 $2,458 - $2,980	189 Added 85.14%	411 $5,000
Q1 2024 Apr 29, 2024	BUY	$14.06 - $16.79 $1,715 - $2,048	122 Added 122.0%	222 $3,000
Q2 2023 Aug 15, 2023	SELL	$14.1 - $19.83 $2,820 - $3,965	-200 Reduced 66.67%	100 $2,000
Q4 2022 Feb 07, 2023	SELL	$6.45 - $12.07 $1,290 - $2,414	-200 Reduced 40.0%	300 $3,000
Q3 2022 Oct 28, 2022	BUY	$7.86 - $12.91 $786 - $1,291	100 Added 25.0%	500 $4,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $4,666 - $9,234	-661 Reduced 62.3%	400 $3,000
Q1 2022 May 04, 2022	SELL	$12.15 - $35.28 $17,666 - $51,297	-1,454 Reduced 57.81%	1,061 $13,000
Q4 2021 Feb 07, 2022	SELL	$30.49 - $48.49 $182 - $290	-6 Reduced 0.24%	2,515 $86,000
Q3 2021 Nov 02, 2021	SELL	$41.66 - $52.52 $416 - $525	-10 Reduced 0.4%	2,521 $122,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $3,515 - $4,962	-96 Reduced 3.65%	2,531 $114,000
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $15,501 - $22,335	-373 Reduced 12.43%	2,627 $127,000
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $3,608 - $5,647	-100 Reduced 3.23%	3,000 $162,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $33,260 - $40,480	-1,000 Reduced 24.39%	3,100 $114,000
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $4,842 - $6,204	-200 Reduced 4.65%	4,100 $127,000
Q1 2020 May 07, 2020	BUY	$20.5 - $34.53 $4,530 - $7,631	221 Added 5.42%	4,300 $119,000
Q4 2019 Feb 06, 2020	SELL	$18.96 - $29.84 $8,930 - $14,054	-471 Reduced 10.35%	4,079 $119,000
Q3 2019 Nov 05, 2019	BUY	$19.12 - $26.24 $37,284 - $51,168	1,950 Added 75.0%	4,550 $87,000
Q2 2019 Aug 08, 2019	BUY	$19.57 - $24.1 $50,882 - $62,660	2,600 New	2,600 $57,000

Others Institutions Holding NEO

# of Institutions

279

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.78B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Neogenomics Inc Transaction History